1-11 of 11
Sheng Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Expression Signature and Prognostic Value of BCL2 Translocation for Diffuse Large B-Cell Lymphoma Patients in China

Yan Qin, Tian Qiu, Xinrui Chen, Peng Liu, Jianliang Yang, Xiaohui He, Lin Gui, Shengyu Zhou, Hongxin Jiang, Changgong Zhang, Sheng Yang, Le Tang, Yuankai Shi
Journal: Blood
Blood (2022) 140 (Supplement 1): 12094–12095.
https://doi.org/10.1182/blood-2022-162307
Published: 2022
Journal Articles

MYD88 L265P Mutation and Other Variants Show Different Molecular Characteristics in Diffuse Large B-Cell Lymphoma Treated with R-CHOP in China

Yan Qin, Tian Qiu, Zucheng Xie, Peng Liu, Jianliang Yang, Xiaohui He, Lin Gui, Shengyu Zhou, Hongxin Jiang, Changgong Zhang, Sheng Yang, Le Tang, Yuankai Shi
Journal: Blood
Blood (2022) 140 (Supplement 1): 9512–9513.
https://doi.org/10.1182/blood-2022-162907
Published: 2022
Journal Articles

Efficacy and Safety of PD-1 Inhibitor Plus Rituximab in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Yan Qin, Xiaohui He, Sheng Yang, Peng Liu, Shengyu Zhou, Jianliang Yang, Lin Gui, Qiaofeng Zhong, Fengyi Zhao, Yuankai Shi, Hongmei Jing, Shiyue Zhang, Ruihan Guo, Yuankai Shi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2485.
https://doi.org/10.1182/blood-2021-152094
Published: 2021
Journal Articles

Development and Validation of a Novel Prognostic Nomogram Model and a Web-Based Survival Rate Calculator for Diffuse Large B-Cell Lymphoma in the Rituximab Era

Qiaofeng Zhong, Haizhu Chen, Yan Qin, Xiaohui He, Sheng Yang, Shengyu Zhou, Peng Liu, Yuankai Shi, Hongmei Jing
Journal: Blood
Blood (2021) 138 (Supplement 1): 1450.
https://doi.org/10.1182/blood-2021-154210
Published: 2021
Journal Articles

A Prognostic Nomogram and Survival Analysis in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients

Shiyu Jiang, Yan Qin, Peng Liu, Jiangliang Yang, Sheng Yang, Xiaohui He, Shengyu Zhou, Lin Gui, Changgong Zhang, Liqiang Zhou, Ming-Zhe Han, Yan Sun, Yuankai Shi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2994.
https://doi.org/10.1182/blood-2018-99-116442
Published: 2018
Journal Articles

Results from a Prospective, Dose Escalating, Prophylaxis Study in Young Boys with Severe Hemophilia a in China: The China Hemophilia Individualized Prophylaxis Study (CHIPS) (NCT02999308)

Runhui Wu, MD PhD, Wanru Yao, Xiaobo Luo, Ling Tang, Min Zhou, Yan Wang, Ping Ding, Ningning Zhang, Sheng Yang, Pamela Hillard, Koyo Usuba, Nancy Young, Andrea Doria, MD PhD MSc, Audrey Abad, Zhenping Chen, PhDMD, Yun Peng, Junde Wu, MD, Koon-Hung Luke, Victor S. Blanchette, MD, Xiaojing Li, Qing Zhang
Journal: Blood
Blood (2017) 130 (Supplement 1): 3683.
https://doi.org/10.1182/blood.V130.Suppl_1.3683.3683
Published: 2017
Journal Articles

Treatment Outcome and Prognostic Model for Stage IE/IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Retrospective Study in a Cohort of 305 Patients with Long Term Follow-up

Yuankai Shi, MD PhD, Bo Jia, Xiaohui He, MD, Youwu Shi, Mei Dong, MD, Jianliang Yang, MD, Liqiang Zhou, MD, Shengyu Zhou, MD, Peng Liu, MD, Yan Qin, MD, Sheng Yang, MD, Hua Lin, MD, Lin Gui, MD, Changgong Zhang, MD, Lin Wang, MD, Shanshan Chen, MD, Puyuan Xing, MD, Hongnan Mo, MD, Mingzhe Han, MD
Journal: Blood
Blood (2015) 126 (23): 2718.
https://doi.org/10.1182/blood.V126.23.2718.2718
Published: 2015
Journal Articles

Clinical Features and Prognosis of CD20-Positive Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) in Chinese Patients: A Retrospective Single Institution Analysis

Shaoxuan Hu, Xiaohui He, MD, Yuankai Shi, MD PhD, Sheng Yang, MD, Yan Qin, MD, Jianliang Yang, MD, Mei Dong, MD, Shengyu Zhou, MD, Peng Liu, MD, Lin Gui, MD, Changgong Zhang, MD, Liqiang Zhou, MD
Journal: Blood
Blood (2015) 126 (23): 5045.
https://doi.org/10.1182/blood.V126.23.5045.5045
Published: 2015
Journal Articles

Efficacy and Safety of Gemcitabine-Based Combination Regimens in Patients with Extranodal Natural Killer/T Cell Lymphoma, Nasal Type

Jingjing Wang, Mei Dong, MD, Xiaohui He, MD, Weihu Wang, MD, Peng Liu, MD, Jianliang Yang, MD, Yan Qin, MD, Lin Gui, MD, Sheng Yang, MD, Yexiong Li, MD PhD, Yuankai Shi, MD PhD, Lugui Qiu, MD
Journal: Blood
Blood (2014) 124 (21): 3071.
https://doi.org/10.1182/blood.V124.21.3071.3071
Published: 2014
Journal Articles

Deferasirox Inhibit Doxorubicin-Induced Reactive Oxygen Species Generation in Both Acute Myeloid Leukemia and Normal Heart Cell While Maintain the Cytotoxicity of Doxorubicin Only on Acute Myeloid Leukemia

Su-Peng Yeh, MD, Yu-Chien Chang, Wen-Jyi Lo, Min-Lih Huang, Yang-Sheng Yang, Pei Ching Hsiao, Dian-Kun Li, MD
Journal: Blood
Blood (2012) 120 (21): 3620.
https://doi.org/10.1182/blood.V120.21.3620.3620
Published: 2012
Journal Articles

High Efficacy and Good Tolerability with Rituximab In Vivo Purging Followed by High Dose Chemotheraphy and Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) in Non-Hodgkin’s Lymphoma (NHL).

Yuankai Shi, M.D., Sheng Yang, M.D., Xiaohong Han, M.D., Peng Liu, M.D., Xiaohui He, M.D., Jun Ma, M.D., Hanyun Ren, M.D., Xi’nan Cen, M.D., Shuyuan Zhou, M.D., Chun Wang, M.D.
Journal: Blood
Blood (2004) 104 (11): 4626.
https://doi.org/10.1182/blood.V104.11.4626.4626
Published: 2004